Russ Hawkinson - 02 May 2022 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Reporting relationship: Sr. Vice President of Finance
Issuer ticker: SPRY
Reported as of: 02 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 May 2022, 17:00:02 UTC
Prior SEC filing: 02 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey C. Pepe, Attorney-in-Fact

Key filing fact

Russ Hawkinson filed Form 4 for Silverback Therapeutics, Inc. (SPRY) on 04 May 2022.

Key facts

This page summarizes Russ Hawkinson's Form 4 filing for Silverback Therapeutics, Inc. (SPRY).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 May 2022, 17:00.

Change

Previous filing in this sequence was filed on 02 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPRY transaction

Common Stock

Award

Transaction value: $0
Shares: +28,335
Change %: +318%
Price: $0.000000
Shares after: 37,251
Date: 02 May 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SPRY transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +56,670
Change %
Price: $0.000000
Shares after: 56,670
Date: 02 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 56,670
Exercise price: $3.15
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

The shares subject to the option will vest on May 2, 2023.